Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia
Open Access
- 31 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 10 (1), 1-7
- https://doi.org/10.1038/s41598-020-71386-z
Abstract
Acute myeloid leukemia (AML) is one of the most common types of leukemia. With the recent advances in sequencing technology and the growing body of knowledge on the genetics of AML, there is increasing concern about cancer predisposing germline mutations as well as somatic mutations. As familial cases sharing germline mutations are constantly reported, germline predisposition gene mutations in patients with AML are gaining attention. We performed genomic sequencing of Korean patients diagnosed with AML to identify the prevalence and characteristics of germline predisposition mutations. Among 180 patients, germline predisposition mutations were identified in 13 patients (13/180, 7.2%, eight adults and five children). Germline mutations of BLM, BRCA1, BRCA2, CTC1, DDX41, ERCC4, ERCC6, FANCI, FANCM, PALB2, and SBDS were identified. Most of the mutations are in genes involved in DNA repair and genomic stability maintenance. Patients harboring germline mutations tended to have earlier onset of AML (p = 0.005), however, the presence of germline mutations did not showed significant association with other clinical characteristics or treatment outcome. Since each mutation was rare, further study with a larger number of cases would be needed to establish the effect of the mutations.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2018R1C1B6005185)
This publication has 21 references indexed in Scilit:
- Multifaceted Fanconi Anemia SignalingTrends in Genetics, 2017
- Myeloid neoplasms with germline DDX41 mutationInternational Journal of Hematology, 2017
- Dyskeratosis CongenitaNew England Journal of Medicine, 2017
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- Inherited and Somatic Defects in DDX41 in Myeloid NeoplasmsCancer Cell, 2015
- Pathophysiology and management of inherited bone marrow failure syndromesBlood Reviews, 2010
- Replication stress induces sister-chromatid bridging at fragile site loci in mitosisNature, 2009
- Genetic Heterogeneity among Fanconi Anemia Heterozygotes and Risk of CancerCancer Research, 2007
- A variant of the Cockayne syndrome B geneERCC6 confers risk of lung cancerHuman Mutation, 2007
- Heterozygosity for the BLM(Ash) mutation and cancer risk.2003